Uruganda rutanga mu buryo butaziguye 4-Dibuthylamino-2-Hydroxybenzophenone-2-Acide Carboxylic (BBA) CAS 54574-82-2

Mubisanzwe dutekereza kandi tugakora imyitozo ijyanye nimpinduka zawe, hanyuma tugakura.Dufite intego yo kugera kumitekerereze ikungahaye hamwe numubiri wongeyeho ubuzima bwuruganda rutanga mu buryo butaziguye 4-Dibuthylamino-2-Hydroxybenzophenone-2-Acide Carboxylic Acide (BBA) CAS 54574-82-2, Intego yacu yaba iyo gufasha abakiriya kumenya intego zabo .Twagiye dukora ibishoboka byose kugirango tugere kuri iki kibazo cyo gutsinda-kandi tubakuye ku mutima ko mwatwiyandikishije.
Mubisanzwe dutekereza kandi tugakora imyitozo ijyanye nimpinduka zawe, hanyuma tugakura.Dufite intego yo kugera kumitekerereze ikungahaye numubiri wongeyeho kubahoUbushinwa 4-Dibuthylamino-2-Hydroxybenzophenone na Bba, Guhora tubona ibicuruzwa byo mu rwego rwo hejuru hamwe nibisubizo bifatanije na serivise nziza yo kugurisha mbere na nyuma yo kugurisha itanga irushanwa rikomeye ku isoko ryiyongera ku isi.urakaza neza abakiriya bashya nabakera baturutse imihanda yose kugirango batubwire umubano wubucuruzi uzaza hamwe no gutsinda!

2′-Methoxy-3′-nitro-biphenyl-3-karubasi ya acide ikoreshwa nka interineti ya Eltrombopag.
Eltrombopag, yakozwe na GlaxoSmithKline (GSK) mu Bwongereza nyuma iza gukorana na Novartis mu Busuwisi, ni yo ya mbere kandi yemewe ya molekile ntoya itari peptide TPO yakira agonist ku isi.Eltrombopag yemejwe na FDA yo muri Amerika muri 2008 kugirango ivure idiopathic trombocytopenic purpura (ITP), naho muri 2014 yo kuvura anemia ikabije (AA).Ninumuti wambere wemejwe na FDA yo muri Amerika kuvura AA mumyaka 30 ishize.
Ukuboza2012, FDA yo muri Amerika yemeye Eltrombopag kuvura trombocytopenia ku barwayi barwaye hepatite C idakira (CHC), ku buryo abarwayi ba hepatite C bafite uburwayi buke buterwa na platine nkeya bashobora gutangira kandi bagakomeza kuvura bisanzwe bishingiye ku ndwara z’umwijima.Ku ya 3 Gashyantare 2014, GlaxoSmithKline yatangaje ko FDA yatanze impamyabumenyi y’ubuvuzi ya Eltrombopag yo kuvura indwara ya hémopenia ku barwayi bafite imiti ikaze y’imiti idakira (SAA) ititabira byimazeyo ubudahangarwa bw'umubiri.Ku ya 24 Kanama 2015, FDA yo muri Amerika yemeje Eltrombopag kuvura trombocytopenia ku bantu bakuru ndetse n’abana bafite imyaka 1 n’imyaka irenga hamwe na immunite trombocytopenia idakira (ITP) badafite ibisubizo bidahagije kuri corticosteroide, immunoglobuline cyangwa splenectomy.Ku ya 4 Mutarama 2018, Eltrombopag yemerewe gushyirwa ku rutonde mu Bushinwa kugira ngo ivurwe mbere na mbere na trombocytopenia (ITP).

Mubisanzwe dutekereza kandi tugakora imyitozo ijyanye nimpinduka zawe, hanyuma tugakura.Dufite intego yo kugera kumitekerereze ikungahaye hamwe numubiri wongeyeho ubuzima bwuruganda rutanga mu buryo butaziguye 4-Dibuthylamino-2-Hydroxybenzophenone-2-Acide Carboxylic Acide (BBA) CAS 54574-82-2, Intego yacu yaba iyo gufasha abakiriya kumenya intego zabo .Twagiye dukora ibishoboka byose kugirango tugere kuri iki kibazo cyo gutsinda-kandi tubakuye ku mutima ko mwatwiyandikishije.
Uruganda rutangwaUbushinwa 4-Dibuthylamino-2-Hydroxybenzophenone na Bba, Guhora tubona ibicuruzwa byo mu rwego rwo hejuru hamwe nibisubizo bifatanije na serivise nziza yo kugurisha mbere na nyuma yo kugurisha itanga irushanwa rikomeye ku isoko ryiyongera ku isi.urakaza neza abakiriya bashya nabakera baturutse imihanda yose kugirango batubwire umubano wubucuruzi uzaza hamwe no gutsinda!